Medical Condition News

RSS

MGH, MIT partner to accelerate development of diagnostic tools and therapies

A novel partnership between Massachusetts General Hospital and Massachusetts Institute of Technology is addressing three major challenges in clinical medicine – improving the diagnosis of disease, developing new approaches to prevent and treat infectious and autoimmune diseases, and developing more accurate methods of diagnosing and treating major neurodegenerative and psychiatric diseases. While individual collaborations between MGH and MIT investigators are nothing new, this formalized strategic partnership is designed to accelerate the development of diagnostic tools and therapies.

16 Oct 2014

UCSF study: Smoking takes $18.1 billion toll in California

Smoking took an $18.1 billion toll in California – $487 for each resident – and was responsible for more than one in seven deaths in the state, more than from AIDS, influenza, diabetes or many other causes, according to the first comprehensive analysis in more than a decade on the financial and health impacts of tobacco.

16 Oct 2014

Major scientific breakthrough in understanding retinal degenerative diseases that cause blindness

An important scientific breakthrough by a team of IRCM researchers led by Michel Cayouette, PhD, is being published today by The Journal of Neuroscience. The Montréal scientists discovered that a protein found in the retina plays an essential role in the function and survival of light-sensing cells that are required for vision.

16 Oct 2014

Use of electronic health care services to improve cardiovascular health in China

The use of electronic health care services (versus more traditional methods) to reduce the high incidence of heart disease in China will be debated by leading cardiologists from around the world in Beijing, from 16 to 19 October 2014.

16 Oct 2014

TxCell to provide overview of T cellular therapy at 7th National Bio-Therapy Conference

TxCell SA, a biotechnology company developing innovative, personalized cell-based immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that Dr. Miguel Forte, Sr. VP Clinical Development and Regulatory Affairs, TxCell, will present on T cellular therapy for autoimmune diseases at the 7th National Bio-Therapy Conference, October 24-26, 2014 at Great Tang Hotel, Shanghai, China.

16 Oct 2014

Reducing heart failure deaths: an interview with Dimitrios Georgiopoulos, UK Medical Director, Novartis

Heart failure is a debilitating, and life-threatening, condition in which the heart cannot pump enough blood around the body. When heart failure continues to progress and worsen over time, the persistent condition is known as chronic heart failure.

From Novartis 16 Oct 2014

New study reviews modern treatment modalities for early-stage lung cancer

Removal of the entire lobe of lung may offer patients with early-stage lung cancer better overall survival when compared with a partial resection, and stereotactic ablative radiotherapy (SABR) may offer the same survival benefit as a lobectomy for some patients, according to a study from The University of Texas MD Anderson Cancer Center.

16 Oct 2014

Research on zebrafish helps identify cause of unknown genetic disorder

Research in zebrafish has helped identify the cause of an unknown genetic disorder affecting a boy and two of his uncles, scientists report in an article published October 14 in the journal GENETICS.

16 Oct 2014

Scientists combine new type of nanoparticle with photodynamic therapy to kill cancer cells

An international group of scientists led by Gang Han, PhD, at the University of Massachusetts Medical School, has combined a new type of nanoparticle with an FDA-approved photodynamic therapy to effectively kill deep-set cancer cells in vivo with minimal damage to surrounding tissue and fewer side effects than chemotherapy. This promising new treatment strategy could expand the current use of photodynamic therapies to access deep-set cancer tumors.

16 Oct 2014

New treatment strategy may improve repair process after heart attack

In a study that could point the way toward a new strategy for treating patients after a heart attack, UCLA stem cell researchers led by associate professor of medicine (cardiology) and Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research member Dr. Arjun Deb have discovered that some scar-forming cells in the heart, known as fibroblasts, have the ability to become endothelial cells (the cells that form blood vessels).

16 Oct 2014

Sheffield researchers find vital new evidence on how to reverse effects of Parkinson's mutation

Researchers from the University of Sheffield have found vital new evidence on how to target and reverse the effects caused by one of the most common genetic causes of Parkinson's.

16 Oct 2014

Vanderbilt engineers develop robotic device for less invasive epilepsy surgery

For those most severely affected, treating epilepsy means drilling through the skull deep into the brain to destroy the small area where the seizures originate - invasive, dangerous and with a long recovery period.

16 Oct 2014

Researchers define the process of Parkinson's disease using genetic mouse model

Parkinson's Disease is the second most common neurodegenerative disorder. In Germany alone, almost half a million people are affected. The focus of the disease is the progressive degeneration of dopamine-producing nerve cells in a certain region of the midbrain, the substantia nigra. Misfolded proteins are the cause. Until recently, it was unclear why damage is confined to specific nerve cells.

16 Oct 2014

Caregivers more aware of SUDEP than patients

Sudden unexpected death in epilepsy (SUDEP) is concerning and many—even those with seizure disorders—may not be aware of this condition. New research published in Epilepsia, a journal published by Wiley on behalf of the International League Against Epilepsy (ILAE), reports that 76% of caregivers are more likely to have heard of SUDEP compared with 65% of patients with epilepsy.

16 Oct 2014

Treeway, LACDR join forces to optimize clinical trial designs, data-analysis for ALS

Treeway and LACDR at the University of Leiden join forces and form a collaboration focused on the optimization of clinical trial designs and data-analysis for ALS (Amyotrophic Lateral Sclerosis) through the use of population disease progression models.

16 Oct 2014

SIRT6 protein inhibits liver and colon cancers, but promotes skin cancer caused by ultraviolet light

A new study published in Cancer Research shows SIRT6—a protein known to inhibit the growth of liver and colon cancers—can promote the development of skin cancers by turning on an enzyme that increases inflammation, proliferation and survival of sun-damaged skin cells.

16 Oct 2014

ASU hosts 2014 Collaborative Research in Computational Neuroscience meeting for investigators

Across the country, billions of dollars and millions of hours are spent on studying the inner workings of the brain as scientists search for ways to treat debilitating diseases and injuries such as Alzheimer's, Parkinson's, epilepsy, and traumatic brain injury. Now, with the tremendous growth in basic knowledge driven by these efforts, researchers see a need to integrate their work across the broad scientific disciplines represented in modern neuroscience.

16 Oct 2014

Boehringer Ingelheim's OFEV (nintedanib) capsules receive FDA approval for IPF treatment

Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration approved OFEV (nintedanib) capsules for oral use for the treatment of idiopathic pulmonary fibrosis (IPF).

15 Oct 2014

University of Alicante develops tool for people with autism spectrum disorders

The University of Alicante has developed, together with centres in the UK, Spain and Bulgaria, a tool designed to assist people with autism spectrum disorders by adapting written documents into a format that is easier for them to read and understand. This is the main result of the three-year project FIRST (A Flexible Interactive Reading Support Tool), funded by the European Commission under the Seventh Framework Programme.

15 Oct 2014

NeuroSigma, VA partner to evaluate eTNS system for TBI patients in Phase I clinical trial

NeuroSigma, Inc., a California-based life sciences company focused on commercialization of its non-invasive Monarch eTNS System for the treatment of neurological and neuropsychiatric disorders, today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the U.S. Veterans Affairs for a clinical trial to evaluate the benefits of non-invasive, external Trigeminal Nerve Stimulation (eTNS) for patients with traumatic brain injury (TBI) in a Phase I clinical trial.

15 Oct 2014

Medical Condition News

MGH, MIT partner to accelerate development of diagnostic tools and therapies

UCSF study: Smoking takes $18.1 billion toll in California

Major scientific breakthrough in understanding retinal degenerative diseases that cause blindness

Use of electronic health care services to improve cardiovascular health in China

TxCell to provide overview of T cellular therapy at 7th National Bio-Therapy Conference

Reducing heart failure deaths: an interview with Dimitrios Georgiopoulos, UK Medical Director, Novartis

New study reviews modern treatment modalities for early-stage lung cancer

Research on zebrafish helps identify cause of unknown genetic disorder

Scientists combine new type of nanoparticle with photodynamic therapy to kill cancer cells

New treatment strategy may improve repair process after heart attack

Sheffield researchers find vital new evidence on how to reverse effects of Parkinson's mutation

Vanderbilt engineers develop robotic device for less invasive epilepsy surgery

Researchers define the process of Parkinson's disease using genetic mouse model

Caregivers more aware of SUDEP than patients

Treeway, LACDR join forces to optimize clinical trial designs, data-analysis for ALS

SIRT6 protein inhibits liver and colon cancers, but promotes skin cancer caused by ultraviolet light

ASU hosts 2014 Collaborative Research in Computational Neuroscience meeting for investigators

Boehringer Ingelheim's OFEV (nintedanib) capsules receive FDA approval for IPF treatment

University of Alicante develops tool for people with autism spectrum disorders

NeuroSigma, VA partner to evaluate eTNS system for TBI patients in Phase I clinical trial

Obesity, GLP-1s, and metabolic care

Automation in cell-based workflows

Data management challenges in scientific research

Latest News